In therapeutics, APP and MALAT1 played oncogenic roles in the migration of PCa cells, where the former sponged miR-218 to facilitate the expression of ZEB2/CDH2 and the latter modulated PCa progression via the MALAT1-miR-1-KRAS axis [47, 48]. The gene discussed is KRAS; the disease is posterior cortical atrophy.